Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2022 ∙ Fudman, D. I. Perez-Reyes, A. E. Niccum, B. A. Melmed, G. Y. Khalili, H.

Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Wang, Z. Chen, S. Fang, Y.

Parental Willingness and Associated Factors of Pediatric Vaccination in the Era of COVID-19 Pandemic: A Systematic Review and Meta-Analysis

  • All age groups
  • Parents/caregivers
  • Pneumococcal disease
  • Human papillomavirus (HPV)
  • Influenza
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Tvedskov, E. S. F. Hovmand, N. Benfield, T. Tinggaard, M.

Pneumococcal carriage among children in low and lower-middle-income countries: A systematic review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Shao, W. Chen, X. Zheng, C. Wang, G. Zhang, B. Zhang, W.

Pneumococcal vaccination coverage and willingness in mainland China

  • Western Pacific
  • China
  • All age groups
  • Healthcare workers
  • Pneumococcal disease
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Syeed, M. S. Ghule, P. Le, L. M. Veettil, S. K. Horn, E. K. Perdrizet, J. Wasserman, M. Thakkinstian, A. Chaiyakunapruk, N.

Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies

  • Children
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Bencina, G. Fues Wahl, H. Tsoumani, E. Salomonsson, S.

Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: a systematic literature review

  • Europe
  • Children
  • Pneumococcal disease
  • Economic aspects
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Sabbar, H. Mahraoui, C. Bastìas Garcià, M. Jroundi, I.

Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tantawichien, T. Hsu, L. Y. Zaidi, O. Bernauer, M. Du, F. Yamada, E. Kim, J. O. Sukarom, I.

Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas

  • South-East Asia
  • Western Pacific
  • Adults
  • Older adults
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Izurieta, P. Scherbakov, M. Nieto Guevara, J. Vetter, V. Soumahoro, L.

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Castrejon, M. M. Leal, I. de Jesus Pereira Pinto, T. Guzmán-Holst, A.

The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis

  • Americas
  • All age groups
  • Diphtheria
  • Pertussis
  • Tetanus
  • Hepatitis B
  • Haemophilus influenzae type B
  • Poliomyelitis
  • Measles
  • Rotavirus
  • Pneumococcal disease
  • Tuberculosis
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...